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Transformation of  embryonic cells  from various species  by oncogenic viruses 
is associated with large increases in production of  plasminogen activators,  and 
similar enzymes are released by cultures and/or cell  lines  derived from human 
and animal neoplasms. These enzymes activate plasminogen by limited prote- 
olysis, and several of them have been identified  as serine proteases because 
they  are irreversibly inactivated by low concentrations  of the  active site 
reagent diisopropylfluorophosphate  (DFP,  1 1-6).  The stability  of the covalent 
bond formed by the incorporation of radioactive DFP  into  serine residues at 
active sites  (7, 8) can be used to label  both plasminogen activators and other 
serine enzymes; subsequent analysis of  the reaction products by gel  electropho- 
resis and autoradiography  should yield an identifiable  spectrum of labeled 
species that might provide insights  about the secretory  activities  of cultured 
cells. 
In this paper we present the initial  results of such an approach to the 
comparison of serine enzymes released by transformed embryonic cells  and 
their normal  counterparts.  To  differentiate  between  serine proteases  and 
esterases,  and to obtain information about substrate specificity,  we have taken 
advantage  of the fact that incorporation of DFP  can be blocked by prior 
reaction of  enzymes with other active  site  reagents. The combination of  these 
reactions can be used as a general procedure for identification  of individual 
proteases in impure mixtures and particularly  so for enzymes that are present 
at concentrations too low to permit detection  by more traditional  methods. We 
have also  applied these methods to conditioned medium from several cultured 
human  cell  strains  of neoplastic origin  with a view of comparing the serine 
enzymes secreted by a variety of  independently-derived cell  types. 
Materials and Methods 
Cell Culture and Virus Infection.  Cell cultures were prepared and maintained essentially as 
described by Unkeless et al.  (1) using disposable plastic Petri dishes (100 mm diameter, Falcon 
Plastics, Division of BioQuest, Oxnard, Calif.) at 37°C in atmospheric air supplemented with 5% 
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of CO2.  The medium was Dulbecco's modified (9) Eagle's medium supplemented with 10%  (vol/ 
vol) fetal bovine serum.  Mouse embryo cells prepared from C57 black embryos were seeded at a 
density of 2 x  10  e cells per plate. The cells were allowed to attach and grow for 16 h, were treated 
with 1 ml diethylaminoethyldextran (25/~g/ml, Pharmacia Fine Chemicals, Inc., Piscataway, N. 
J.) for 30 rain, and infected with mouse sarcoma virus (MSV, obtained from Dr. H. M. Temin at the 
University of Wisconsin at Madison). Mock infected control cultures were treated in the same way 
as the infected cells except that no virus was added. Human neoplastic cell strains derived from a 
melanoma and a rhabdomyosarcoma (obtained from Dr. D. B. Rifkin, [5]) were seeded at a density 
of 2  ×  106 cells per plate. 
Serum-Free Culture Fluid.  Cultures that had grown to confluency were washed three times 
with a  buffer containing 0.01 M NaPO4,  pH 7.4,  0.15 M  NaC1,  1 rnM CaC12, and 0.5 mM MgC12, 
and then incubated in 10 ml of serum-free medium for 16 h to yield conditioned culture fluid. The 
cell density at this stage was kept in the range 10-16 x  10  e per 100 mm plate. The cells were then 
recycled  for  8  h  in  medium  containing  10%  serum  before  further  incubation  in  serum-free 
medium  and  the  procedure  was  repeated  up  to  five  times.  The  conditioned  medium  was 
centrifuged  (5000  g,  10  rain)  at  4°C,  the  resulting supernate  placed  into  dialysis  tubes  and 
concentrated 10-fold by packing in dry Sephadex G-150 at 4°C, and finally dialyzed against 0.1 M 
Tris-sulphate, pH 7.4, for 48 h  at 4°C.  Protein content in the concentrated and dialyzed medium 
was measured by the method of Lowry et al.  (10). 
Assay for Plasminogen Activator.  Assays for fibrinolysis initiated by plasminogen activation 
were performed in plastic Petri dishes coated with bovine [125I]fibrin  as described previously (3). 
The assays were performed in 0.1 M Tris HC1,  pH 8.1 containing 2 ~g of human plasminogen in a 
final vol of 1 ml; incubation was at  37°C  for the periods indicated in each experiment.  1 U  of 
plasminogen activator was defined as the amount which released 5% of the radioactivity in 1 h 
from freshly activated plates. 
[l~SI]bovine fibrinogen was prepared as described by Unkeless et al.  (1).  Human plasminogen 
was prepared from plasma according to the method of Deutsch and Mertz (11) by two cycles of 
affinity chromatography on columns of Sepharose 4 B substituted with L-lysine. 
Labeling  with [SH]DFP.  Concentrated and  dialyzed  conditioned  culture  fluid  (1.5-2.5  ml) 
was incubated with [3H]DFP (50 ~M,  3.9-10 Ci/mmol) for 16 h  at 20°C,  dialyzed for 48 h  at 4°C 
against distilled water containing sodium dodecyl sulfate (SDS), lyophilized, and dissolved in 50 
~1 of a  buffer containing 10%  glycerol,  5%  ethylene  glycol,  0.062  M  Tris  HC1,  pH  6.8.  When 
labeling was performed in the presence of other competing protease inhibiters the latter were 
preincubated with concentrated conditioned  medium  for  1  h  before addition of [~H]DFP.  The 
concentration of SDS was equalized on both sides of the dialysis membrane and it was adjusted 
to yield a final concentration of 5% after lyophilizing and redissolving the sample in 50 ~1 buffer. 
Gel Electrophoresis.  SDS-pelyacrylamide  gel  electrophoresis  was  performed  in  a  stacking 
system (12),  with slab gels (1.2  ×  130  x  150 ram) with acrylamide concentrations as indicated in 
each case,  and with a  stacking layer consisting of 4% acrylamide.  Buffers were as described by 
Laemmli (12).  The gels were stained with 0.1% Coomassie Blue in 50% (wt/vol) trichloroacetic 
acid, and destained in 10% acetic acid. A mixture of protein markers was electrophoresed in each 
gel.  These included basic pancreatic trypsin inhibitor (tool wt 6,500),  lysozyme (tool wt 14,000), 
chymotrypsinogen (tool wt 25,000),  ovalbumin (tool wt 45,000),  bovine serum albumin (tool wt 
68,000),  fl-galactosidase (tool wt 130,000),  and bovine fibrinogen (tool wt 320,000).  After electro- 
phoresis some gels were sectioned longitudinally, each channel was frozen and cut into 1.l-ram 
slices  with  a  fakir  bed  of razor  blades,  and  the  slices  assayed  for  plasminogen  activator  as 
described above. To assay for [3H]DFP the slices were incubated for 72 h  at 37°C in a  mixture of 
Liquifluor/protosol/4  M  ammonium hydroxide  (50/5/1,  vol/vol/vol) and counted in scintillation 
counter  (Packard Instrument Co.,  Inc.,  Downers Grove, Ill.,  counting efficiency 30%);  alterna- 
tively, [3H]DFP was detected in the gels by scintillation autoradiography as described by Bonner 
and Laskey (13). 
Chemicals.  The  chemicals  used  in  this  work  were  obtained  as  follows:  [3H]DPF  from 
Amersham Corp.,  Arlington Heights,  Ill.;  urokinase Leo from Leo Pharmaceutical Industries, 
Ballerup,  Denmark; p-nitrophenyl-p'-guanidinobenzoate  (NPGB)  and tert-butoxycarbonyl-ala- 
ala-pro-ala-p-nitroanilide  and  basic  pancreatic  trypsin  inhibitor  were  gifts  from  Doctors  E. 
Shaw,  M. Zimmerman, and E. Truscheit, respectively; acrylamide, N,N,N',N'-tetramethylenedi- 
amine, N,N'-methylene bisacrylamide, ammonium persulfate, X-ray film RP/R54, and dimethyl KELD  DAN0  AND  E.  REICH  747 
sulphoxide were from Eastman Kodak Co.,  Rochester, N. Y.; Sephadex G-150 and Sepharose-4B 
from Pharmacia Fine Chemicals;  SDS (specially  pure) from BDH  Chemicals,  Poole, England; 
[1251]sodium  iodide (carrier  free)  from Schwartz-Mann Div., Becton, Dickinson &  Co. Biochemi- 
cals, Orangeburg, N. Y.; protosol and Liquifluor from New  England Nuclear Corp., Boston, 
Mass.; Eagle's minimal essential  medium, Dulbecco modified Eagle's medium, and fetal  bovine 
serum from Grand Island Biological,  Co.,  Grand Island,  N. Y. All other reagents were of  the  best 
commercially available grade. 
Results 
Analysis of Conditioned  Media from Cultures  of Normal and Transformed 
Mouse Embryo Cells.  Serum-free  conditioned  media were collected,  concen- 
trated, reacted with [3H]DFP, and analyzed by SDS-pelyacrylamide gel electro- 
phoresis.  As  seen  in  Fig.  1 a,  the  radioactivity  profile  of the  sample  from 
transformed cultures contained four distinct peaks, whereas none were observed 
in the normal control.  Parallel differences in enzyme activity between normal 
and  transformed  cultures  were found in  gels of samples  that  were analyzed 
without having been exposed to DFP (Fig. 1 b). The coincidence of plasminogen 
activator activity and [3H]DFP labeling in two of the peaks (Fig. 1 b and legend 
to Fig.  1) makes it seem likely that at least some of the incorporated DFP was 
due  to  reaction  with  these  trypsin-like  enzymes,  but  the  fractional  labeling 
represented  by such enzymes could not be estimated from these observations 
alone,  as  DFP  can  bind  covalently  to  proteins  other  than  those  containing 
active serine groups  (14-17).  Accordingly, the nature  of the  [3H]DFP reactive 
proteins was characterized further by performing the labeling reaction in the 
presence of a  variety of known, competing, protease inhibitors. 
The results illustrated in Fig. 2 were obtained when conditioned media were 
incubated with  [3H]DFP in presence of NPGB,  an inhibitor that  acylates the 
active site of most known trypsin-like enzymes. In comparison with the results 
in Fig.  1, NPGB blocked the incorporation of [3H]DFP into peaks I and II, but 
not into peaks III (Fig. 1) and IV. Since plasminogen activator is known both to 
share the substrate specificity of trypsin for arginine and lysine residues and to 
be inactivated by NPGB (3, 6, 18), 2 it appears likely that peaks I and II were due 
to enzymes of this class. This conclusion is reinforced by the fact that all of the 
proteolytic activity associated with these two peaks was plasminogen  depend- 
ent. 
Because the concentrations of NPGB that are known to inhibit plasminogen 
activator are rather low (18), 2 the complete block of [3H]DFP labeling in peaks 
I and II (Fig. 2) suggests both that [3H]DFP was bound only at the active site of 
the respective enzymes and that  its incorporation  could provide a  measure of 
the number of enzyme  molecules present.  On this basis the specific catalytic 
activity of peak I  was at  least  10-fold greater than  that  of peak  II when the 
extent of [3H]DFP incorporation was related to enzyme assays as in Fig. 1. 3 We 
have not characterized  the kinetic parameters  of peaks I  and II in detail and 
therefore do not know whether the catalytic differences are due to changes in 
2  K. Dane and E. Reich. 1977.  Plasminogen activator from cells  transformed by oncogenic 
virus:  inhibitors  of  the activation  reaction.  Manuscript submitted for  publication. 
3  Control experiments were performed to ensure that both maximal labeling and complete 
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F,G. 1.  (a) [SH]DFP labeling  and (b)  plasminogen activation  profile  after  gel  electropho- 
resis  of  conditioned medium from cultures  of  normal and MSV-transformed mouse fibro- 
blasts.  15  ml of  medium were concentrated 10-fold,  incubated with pH]DFP (50/~M, 10  Ci/ 
retool)  for 16 h at 20°C,  dialyzed  against 0.17% SDS, lyophilized,  and dissolved  in 50 ~l of 
buffer  (10% glycerol,  5% ethylene glycol,  0.062  M  Tris  HCI, pH 6.8).  Culture  fluids  for  the 
plasminogen activator  assays were treated identically  except that the incubation with 
[3H]DFP was omitted. The samples were electrophoresed  in parallel  on a slab  gel with a 
linear  gradient of 8-13.5% polyacrylamide for 18 h at 6 mA  and 25-50 V. The gel was 
sectioned  longitudinally  and each strip  was frozen  and cut into  1.l-ram  slices  which were 
respectively  (a)  assayed  for  radioactivity  (see  experimental  procedures)  and (b)  assayed  for 
plasminogen activator  in  the [12sI]fibrin  plate  assay for  2 h. (Q  Q)  conditioned  medium 
from MSV-transformed mouse fibroblasts  containing 3,100  U  of plasminogen activator. 
(©  ©) conditioned medium prepared under identical conditions from an equal number 
of normal mouse fibroblasts containing no detectable plasminogen activator activity (less 
than  10  U).  The  localization of marker  proteins in a  stained strip of the  gel  and  the 
estimated molecular weights of the peaks based on  their electrophoretic mobilities are 
indicated.  Prolonged  assays  (results  not  shown)  revealed  some  plasminogen activator KELD  DAN(~  AND  E.  REICH  749 
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Fro. 2.  Effect  of NPGB on [3H]DFP labeling of conditioned medium from MSV trans- 
formed mouse cells. (0  Q) conditioned  medium was labeled with pH]DFP as described 
in Fig. 1; or (O  O) treated identically except that NPGB (100 /~M) was added to the 
concentrated medium 1 h before [3H]DFP. Electrophoresis  and analysis for radioactivity as 
described in legend to Fig. 1 except that the gel was constructed with a gradient of 6-16% 
polyacrylamide. 
Kin,  Vmax, or  both.  It  is  also  not  known  whether  the  observed  catalytic 
differences  are  due  to  a  different  sensitivity  to  the  SDS  present  during 
electrophoresis. 
The radioactivity profiles of [3H]DFP-labeled culture fluids from normal and 
transformed mouse cells (Fig.  i a) consistently showed barely detectable small 
peaks  and  shoulders,  suggesting the  presence of additional  [3H]DFP-labeled 
proteins whose existence might be more convincingly revealed using detection 
methods having greater sensitivity and resolving power. For this purpose, we 
applied  the  method  for  scintillation  autoradiography  recently  reported  by 
Bonnet and Laskey (13) which was designed for use with polyacrylamide gels 
containing tritium-labeled compounds. The results of an experiment comparing 
conditioned media from normal and transformed cultures are presented in Fig. 
3.  The  staining  patterns  obtained from  Coomassie  Blue  (a-d)  show  distinct 
differences between the  normal and  transformed cultures,  but these are not 
detectably  influenced by  NPGB.  Parallel  specimens  were  incubated  before 
electrophoresis with [3H]DFP, in presence or absence of NPGB, and analyzed 
by autoradiography for 5 days (e-h) or 17 days (i-l). As expected, the number of 
[3H]DFP-labeled bands detected was  increased by longer periods of autoradi- 
ographic exposure; after 17 days ofexpesure there were 12 bands in transformed 
cell  conditioned  medium  (Fig.  3k)  and  nine  in  the  normal  (Fig.  3i)  and 
multiple differences between them. Five of the [3H]DFP-labeled proteins (E, F, 
G, H,  and I) were present either exclusively or predominantly in transformed 
cell  conditioned  medium,  while  one  (K)  was  detected  only  in  media  from 
normal  cultures.  Competition experiments with  NPGB  (Fig.  3 f,  h, j,  and  l) 
showed that bands E, F, H, I, and K were trypsin-like proteases, since [3H]DFP 
activity in the culture fluid from MSV-transformed cells corresponding  to peak II in the 
radioactivity profile. The specific  catalytic activity of peak II (calculated as radioactivity 
released in the fibrinolysis assay/[3H]DFP labeling) was more than  10.fold smaller than 
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FIo.  3.  Scintillation  autoradiograms  after  gel electrophoresis  of  conditioned  medium 
from  normal and MSV transformed  mouse fibroblasts  after  incubation  with  [aH]DFP,  in 
the presence  or absence of NPGB.  The samples  were prepared  and electrophoresis 
performed  as  described  in  Fig.  I  a,  except  that  the  specific  activity  of  the  [3H]DFP was  3.9 
Ci/mmol.  The gel  was  stained  and  scintillation  autoradiograms  prepared  as  described  in 
Materials  and  Methods  with  exposure  times  as  indicated.  (a,  e,  and  i):  conditioned  medium 
from  normal cells  labeled  with [3H]DFP.  (b,  f,  and  j):  conditioned  medium from normal 
cells  labeled  with [SH]DFP after  preincubation  with  100 ~M  NPGB.  (c, g, and k): 
conditioned  medium  from  transformed  cells  labeled  with  [~H]DFP.  (d,  h,  and  l):  conditioned 
medium from transformed  cells  labeled  with [SH]DFP after  preincubation  with 100 ~M 
NPGB. The  localization  of  marker  proteins  in  a  stained  lane  of  the  gel,  and  the  estimated 
molecular  weights  of  the  bands based  on  their  electrophoretic  mobilities,  are  indicated. 
Each sample of culture fluid from transformed cells contained 1,420 plasminogen activator 
U while plasminogen activator was not detected in the culture fluid from the normal cells 
(below 3 U). 
incorporation was largely inhibited under these conditions. By comparing the 
results in Fig. 3 with those in Figs. 1 and 2,we can identify  band E  (Fig.  3) as 
the predominant  plasminogen  activator released by transformed  cells.  It is 
significant  that  the  region corresponding to  plasminogen activator accounts for 
most of  the serine enzymes found in transformed culture conditioned medium; 
it is also responsible for the major serine enzyme differences between trans- 
formed and normal cultures. 
To obtain further data concerning bands in  which [3H]DFP labeling  was not 
affected by NPGB,  experiments identical to that of  Fig. 3 were performed by 
using known  inhibitors  with other specificities.  As  seen in Table  I, three 
NPGB-resistant enzymes (D, G, and N) interacted  with other inhibitors;  these 
therefore  probably  represent  serine  esterases  or  proteases, although  this  level  of 
characterization  is  not  sufficient  for  their  definitive  identification.  Two of  these 
(D and N) were in culture medium  from both normal and transformed cells, 
while one (G)  was found  predominantly in  medium  from  transformed cells.  The 
finding  that  the  labeling  of  band E was blocked  by  benzamidine and L-arginine 
methyl ester,  in addition to NPGB,  is consistent with the known  inhibitor 
spectrum of  plasminogen activators from a variety of  species (3, 18).  2 KELD  DANe  AND  E.  REICH  751 
TABLE  I 
Inhibition of [aH]DFP Labeling of Proteins Found in Culture Fluid from MSV-Transformed 
Cells 
Inhibiters  Concentration 
Proteins* 
A  B  C  D  E  F  G  H  I  J  L  M  N 
NPGB  100 
PMSF$  50 
Benzamidin  100,000 
L-Arginine methyl ester  100,000 
TPCK  5O0 
Tert.butoxycarbonyl.ala.ala.  10,000 
pro-ala-p-nitreanilide 
Lima bean trypsin inhibitor  5 
Soybean trypsin inhibiter  5 
Basic  pancreatic  trypsin  in-  35 
hibitor 
+  +  +  + 
+  +  +  +  +  + 
+  --  +  --  + 
+  --  +  -- 
Experimental conditions as described in Fig. 3 except that preincubation with NPGB was substituted by preincubation with the listed 
inhibitors in concentrations as indicated. The letters refer to the bands in Fig. 3k. 
* +  Indicate that [SH]DFP  incorporation was decreased by preincubation  with the inhibitor; -  that it was not. 
$ PMSF, phenyl methyl sulfonyl fluoride; TPCK, L-l.tosyl-2-phenylethylchloromethyl ketene. 
Stained gels (Fig.  3 a,  b,  c,  and d) showed that the culture fluid contained 
considerable amounts of serum albumin.  Addition of radioactive amino acids to 
the cultures did not lead to biosynthetic labeling of the albumin,  which must 
therefore  have  been  a  persisting  serum  contaminant  (unpublished  results). 
This  raised  the  possibility that  some  of the  [3H]DFP-labeled proteins  might 
likewise have been derived from the serum, and a sample of fetal bovine serum 
was  therefore  incubated  with  [3H]DFP and  analyzed  as  described  in  Fig.  3. 
Only  a  single  band  of radioactivity  was  detected;  this  band  migrated  to  the 
same place as did band B in the culture fluids. Hence the other bands detected 
in the culture fluids represent proteins that are either produced by the cells, or 
they are serum proteins that are rendered susceptible to [3H]DFP incorporation 
after exposure to the cultures. 
Considerable differences between the protein contents of fluids from normal 
and transformed mouse cells were observed in the stained gels (Fig. 3 a  and c). 
For  example,  a  consistent  finding  was  the  presence  of two  bands  of high 
molecular weight  (Fig.  3 a,  I,  II) in fluids from  normal  cultures,  which were 
either  reduced in  amount  or absent in fluids from transformed  cells.  Biosyn- 
thetic labeling experiments showed that these two proteins were produced by 
the  normal  cells and  they are probably related  to  the  external  glycoproteins 
studied in many other laboratories (19). 
Neoplastic Cell Strains of  Human Origin.  To obtain information concerning 
enzymes released in cultures of human cells, several cell strains  derived from 
human  tumors  were  surveyed by using  the  approach  described in  Fig.  3 for 
murine material.  The data from two such strains-a rhabdomyosarcoma and a 
melanoma-are  presented in Fig.  4,  where the enzymes in conditioned media 
can be compared with a  preparation  of human  urinary  urokinase  that served 
as a reference standard.  The conditioned medium from rhabdomyosarcoma cells 
contained 10 bands that were labeled with [3H]DFP, that from melanoma cells 
contained nine labeled species, while three proteins in urokinase were labeled 
by [3H]DFP.  Competition experiments with NPGB (Fig.  4 h, j,  l,  n,  p, r,  t,  v, 752  SERINE  ENZYMES  FROM  NEOPLASTIC  CELLS 
FIG.  4.  Scintillation  autoradiogram  obtained  after  gel electrophoresis  of conditioned 
medium  from  two  human  tumor  cell  strains,  and  of  urinary  urokinase:  [aH]DFP  labeling  in 
presence  or absence  of NPGB. Experimental  procedures  as described  in Fig. 3. The 
urokinase  was  dissolved  in  1.5  ml  0.1  M Tris  SO4,  pH  7.2  before  incubation  with  [3H]DFP. 
(a,  g,  m,  and  s):  conditioned  medium  from  rhabdomyosarcoma cells  labeled  with  [SH]DFP. 
(b,  h,  n,  and  t):  conditioned  medium from  rhabdomyosarcoma cells  labeled  with  [3H]DFP 
after  preincubation  with  NPGB. (c,  i,  o,  and  u):  conditioned  medium  from  melanoma  cells 
labeled  with  [3H]DFP.  (d,  j,  p,  and  v):  conditioned  medium from melanoma cells  labeled 
with [3H]DFP after  preincubation  with  NPGB. (e,  k, q, and  w): urokinase  labeled  with 
[3H]DFP.  (f,  l,  r,  and  x):  urokinase  labeled  with  [3H]DFP after  preincubation  with  NPGB. 
Preincubation  with NPGB was for  i  h at 20 ~M. Note:  this  concentration  was fivefold 
lower  than that  used in the experiments  described  in Figs. 2 and 3. The content  of 
plasinogen  activator  was,  respectively:  rhabdomyosarcoma  cells-3,900  U; melanoma 
cells-5,300  U, and  urokinase-8,000  U. 
and x) showed that at least eight of  the labeled bands in rhabdomyosarcoma 
conditioned medium  were serine proteases (B, D, E, F, H, I, J, and M); the 
comparable numbers for melanoma  conditioned medium  and urokinase were 
seven (B, D, E, G, H, J, and K) and two (F and I),  respectively. 
The plasminogen activator profile  of  other samples from the same prepara- 
tions  was  determined  in a  separate gel which was  sliced  and assayed for 
enzymatic activity (Fig.  5). The culture fluid  from rhabdomyosarcoma  cells 
contained four electrophoretically separable plasminogen activators, that  from 
melanoma  cells  two, and urokinase two. Although the resolution of  the gels 
sliced for determination  of catalytic activity was  low  compared  with  the 
autoradiograms  of [3H]DFP  labeling, comparison of the apparent molecular 
weights of  the plasminogen activators and the serine proteases (Figs. 4 and 5) 
led to the following tentative identification:  the plasminogen  activators from 
rhabdomyosarcoma  cells  as the proteases D, E, F, and I (Figs. 4  g, m, s, and 
5  a), the activators from melanoma  cells  as  the proteases D  and E  (Fig.  4  i  and 
5  b),  and the  activators in  urokinase as  the  proteases  F and I  (Figs.  4  k and 5  c). 
Hence,  taken together,  Figs.  4  and  5  show  that two  serine proteases and 
plasminogen activators D  and E  with apparent tool  wt approximately 69,000 
and 63,000 were common  both to rhabdomyosarcoma  and melanoma  cultures 
but were not present in  urokinase. Two serine proteases (F and I)  with tool  wt KELD  DANO  AND  E.  REICH  753 
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FIG.  5.  Plasminogen  activator  profile after  gel electrophoresis  of conditioned  medium 
from human tumor cell strains and urinary urokinase.  Experimental conditions were as 
described in Fig. 1 b except that a 8-16% polyacrylamide gel was used for electrephoresis. 
(a)  Conditioned  medium  from  rhabdomyosarcoma  cells  containing  900  U  plasminogen 
activator.  Gel slices were assayed for 5 h.  (b) Conditioned medium from melanoma cells 
containing 300  U  plasminogen activator.  Gel slices were assayed for 8 h.  (c)  Urokinase 
containing 1,000 U plasminogen activator. Gel slices were assayed for 8 h. 754  SERINE  ENZYMES  FROM  NEOPLASTIC  CELLS 
approximately  58,000  and  36,000,  which  also  were  plasminogen  activators, 
were common to urokinase  and rhabdomyosarcoma conditioned  medium,  but 
neither of these was detected in cuture medium from melanoma cells. Protease 
J,  with a  tool wt approximately 29,000,  which had no detectable plasminogen 
activator  activity was released from both rhabdomyosarcoma  and  melanoma 
cells.  The electrophoretic mobility of this protease was indistinguishable  from 
that of protease H in Fig. 3 g and h, which was previously observed in cultures 
of transformed mouse cells. 
Discussion 
The results in this paper may be considered in the following contexts: (a) the 
utility and applicability of the [3H]DFP labeling method, particularly when'it is 
used in conjunction with enzyme assays and with other, competing, active site 
reagents;  (b)  the  differences  in  serine  enzyme  profiles  found  in  conditioned 
media from normal and transformed cultures; and (c) the properties ofplasmin- 
ogen activators released by different cell types. 
(a) The reaction of DFP with protein is not limited to the active site of serine 
enzymes; DFP can form stable derivatives with the hydroxyl group of tyrosine 
residues,  and with serine  and/or threonine  hydroxyls that  are  not located in 
enzymatically  active  centers  (14-17).  In  spite  of these  shortcomings  there  is 
sound  evidence to suggest that  the  incorporation  of [3H]DFP can  serve  as a 
versatile  and  sensitive  means  for  detecting  and  identifying  serine  enzymes, 
particularly  serine proteases: thus,  (1) both the rate and extent of nonspecific 
reactions are markedly reduced below pH 7.5 and at DFP concentrations below 
millimolar  (14,  20); hence the risk of nonspecific labeling with [3H]DFP can be 
minimized  by  selecting  the  reaction  conditions  appropriately  and  with  the 
reactivity of particular enzymes in mind.  (2) It appears likely that the value of 
[~H]DFP for labeling serine enzymes will be greatest when the reaction is used 
in conjunction with enzyme assays and other enzymatic probes, such as known 
inhibitors.  The  large  repertoire  of  well  studied  trypsin  inhibitors,  which 
includes a variety of macromolecules in addition to both reversible and irrevers- 
ible  active  site  blocking  agents,  provides  a  set  of highly  specific  competing 
reagents for evaluating the tryptic character of a given [3H]DFP-labeled band. 
Similar, though less extensive groups of inhibitors are available for character- 
izing serine enzymes with chymotryptic, elastolytic, and other specificities. 
With the exception of enzymes that function in unusual environments  such 
as the vertebrate stomach, most extracellular proteases are catalytically active 
at pH close to neutrality, they have correspondingly neutral pH optima, and the 
vast  majority  are  serine  enzymes.  Recent  observations, 4 and  the  result  of a 
newly developed method  4 suggest that  most,  and perhaps  all serine proteases 
retain  their  catalytic  activity  aider  SDS-pelyacrylamide  gel  electrophoresis 
under nonreducing conditions and can be visualized at very low concentrations 
as lytic bands.  Thus,  the combination of electrophoretic mobility, appropriate 
assays,  and  DFP  labeling  in  the  presence  and  absence  of inhibitors  should 
allow many of the extracellular  proteases in crude tissue extracts,  or complex 
A.  Piperno and R.  Reich. 1978. Unpublished observations and  manuscript submitted for 
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body fluids, to be detected and identified; metalloproteinases, thiol proteinases, 
and the minority of serine enzymes that react poorly with DFP will obviously 
escape detection by this approach. 
(b) The data in this paper, taken together with previously published work in 
this and other systems (1-3), demonstrate beyond doubt that transformation by 
sarcoma viruses is accompanied by a large increase in synthesis and secretion of 
plasminogen  activators.  In the present work, the increased release of enzyme 
after transformation  by mSV was at least 100-fold;  this is probably a  minimal 
estimate  in  view  of the  fact  that  plasminogen  activator  is  inactivated  in 
conditioned medium.  Because the phenotypic differences between normal  and 
transformed  cells are profound,  a  broad range  of differences in the pattern  of 
secreted enzymes might have been expected; hence, it was somewhat surprising 
to find that,  in terms of the numbers of enzyme molecules released,  the bands 
corresponding to plasminogen  activator accounted for most of the difference in 
[aH]DFP labeling.  This is clearly visible in the 5-day exposed autoradiograms 
in  Fig.  3,  which emphasize  the contrast  both between the normal  and trans- 
formed  cultures  and  between  plasminogen  activator  and  all  other  serine 
enzymes.  The  magnitude  of the  change  in  plasminogen  activator  production 
appears striking,  and the fact that  [3H]DFP labeling and catalytic activity are 
both completely abolished  by low concentrations  of NPGB  (18)  2 supports  the 
assumption that this enzyme accounts for all of the labeling in band E  (Fig. 3). 
Apart  from  plasminogen  activator,  the  data  also  revealed  the  existence  of 
multiple  differences in  serine  enzyme  patterns:  there  were  at  least  six  such 
differences  of  which  four  appeared  to  involve  proteases  with  trypsin-like 
specificity.  Owing to the limited  amount of available information  concerning 
these species we cannot as yet assess their biological significance.  Moreover, it 
remains uncertain whether the other bands are secreted, or are the products of 
contaminating serum zymogens that might have become activated by exposure 
to cultured cells; this is in contrast with plasminogen  activator,  whose status 
as a  cellular secretion product is well documented by several lines of evidence 
(1-6). 
(c) The combined results of [~H]DFP labeling and enzyme assay showed the 
existence of several forms of plasminogen  activator.  In general,  differences in 
the numbers of active bands and in their e!ectrophoretic mobility were greater 
in samples from different species, than they were in a variety of cell types from 
a  single species. It appears likely that the multiplicity of electrophoretic forms 
arises by progressive limited proteolysis of a high molecular weight precursor, 
but the  full documentation  of this  process is beyond the scope of the present 
work. 
Summary 
Serine  proteases  or  esterases  released  from  cell  cultures  into  the  growth 
medium were converted to radioactive derivatives by active site labeling with 
tritiated DFP, both in the presence and absence of other competing active site 
reagents.  The  individual  labeled enzymes were then  identified  by SDS-poly- 
acrylamide gel electrophoresis and scintillation  autoradiography. 
Conditioned  medium  from  embryonal  mouse  fibroblasts  transformed  by 
mouse sarcoma virus contained  five serine enzymes that  were not present  in 756  SERINE  ENZYMES  FROM  NEOPLASTIC  CELLS 
medium from normal cells;  two serine enzymes were released by both cell 
types, and one serine  enzyme was found only in medium from normal cells. 
Two of  the enzymes released  by transformed cells  were identified  as plasmino- 
gen activators;  these accounted for most of the serine  enzyme labeling in 
transformed culture media  and for most of the serine enzyme  difference 
between normal and transformed cultures.  The culture fluids  from two cell 
strains of human neoplastic  origin  were examined by the same method. A 
rhabdomyosarcoma strain  released  eight  serine  enzymes (tool  wt ranging from 
22,500 to 102,000),  four  of which were plasminogen activators;  seven serine 
enzymes (tool  wt 26,000-102,000),  including  two plasminogen activators,  were 
detected  in  medium from  human melanoma cultures.  In  terms  of  electrophoretic 
mobility two of the plasminogen activators  from rhabdomyosarcoma  were 
identical  with those  from melanoma cultures,  while the remaining two rhab- 
domyosarcoma activators  coincided  with activators  found in commercial uroki- 
nase. 
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